Molina Healthcare, Inc. (NYSE:MOH) Shares Purchased by Ronald Blue Trust Inc.

Posted by on Mar 28th, 2023

Ronald Blue Trust Inc. boosted its holdings in Molina Healthcare, Inc. (NYSE:MOH – Get Rating) by 79.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 467 shares of the company’s stock after buying an additional 207 shares during the quarter. Ronald Blue Trust Inc.’s holdings in Molina Healthcare were worth $154,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Private Trust Co. NA acquired a new position in Molina Healthcare in the second quarter worth approximately $25,000. Massmutual Trust Co. FSB ADV grew its position in Molina Healthcare by 64.3% in the third quarter. Massmutual Trust Co. FSB ADV now owns 92 shares of the company’s stock worth $30,000 after buying an additional 36 shares during the last quarter. Guardian Wealth Advisors LLC acquired a new position in Molina Healthcare in the third quarter worth approximately $31,000. Brown Brothers Harriman & Co. acquired a new position in Molina Healthcare in the first quarter worth approximately $40,000. Finally, Accurate Wealth Management LLC acquired a new position in Molina Healthcare in the fourth quarter worth approximately $35,000. Institutional investors and hedge funds own 94.25% of the company’s stock.

Molina Healthcare Trading Up 0.7 %

Molina Healthcare stock opened at $269.64 on Tuesday. The company’s fifty day simple moving average is $286.53 and its 200-day simple moving average is $317.71. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 0.81. Molina Healthcare, Inc. has a 12 month low of $249.78 and a 12 month high of $374.00. The stock has a market cap of $15.71 billion, a P/E ratio of 19.90, a P/E/G ratio of 0.69 and a beta of 0.66.

Molina Healthcare (NYSE:MOH – Get Rating) last posted its quarterly earnings results on Wednesday, February 8th. The company reported $4.10 EPS for the quarter, beating the consensus estimate of $4.06 by $0.04. Molina Healthcare had a net margin of 2.48% and a return on equity of 36.05%. The business had revenue of $8.22 billion for the quarter, compared to analysts’ expectations of $7.87 billion. During the same period in the previous year, the company posted $2.88 EPS. Molina Healthcare’s revenue was up 11.0% on a year-over-year basis. As a group, sell-side analysts forecast that Molina Healthcare, Inc. will post 19.76 EPS for the current fiscal year.

Insider Activity at Molina Healthcare

In related news, Director Daniel Cooperman sold 5,000 shares of Molina Healthcare stock in a transaction on Friday, March 3rd. The shares were sold at an average price of $276.77, for a total value of $1,383,850.00. Following the completion of the sale, the director now owns 4,944 shares of the company’s stock, valued at approximately $1,368,350.88. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.49% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the stock. Stephens reiterated an “equal weight” rating and set a $375.00 price objective on shares of Molina Healthcare in a research report on Thursday, February 9th. JPMorgan Chase & Co. lowered their price objective on shares of Molina Healthcare from $360.00 to $348.00 and set an “overweight” rating on the stock in a research report on Thursday, February 23rd. Barclays lowered their price objective on shares of Molina Healthcare from $400.00 to $375.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 4th. Truist Financial lowered their price objective on shares of Molina Healthcare from $400.00 to $380.00 and set a “buy” rating on the stock in a research report on Friday, February 10th. Finally, Bank of America upgraded shares of Molina Healthcare from an “underperform” rating to a “neutral” rating and set a $388.00 price objective on the stock in a research report on Tuesday, December 13th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, Molina Healthcare has an average rating of “Hold” and a consensus price target of $356.36.

Molina Healthcare Profile

(Get Rating)

Molina Healthcare, Inc engages in the provision of health care services. It operates through the following segments: Medicaid, Medicare, Marketplace, and Other. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA.

Read More

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc. (NYSE:MOH – Get Rating).

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.